Replies to post #221535 on Biotech Values

[ghmm]

I saw someone tweet something about Roches IL-2 showing activity in monotherapy. I haven't seen the data though.

Should add that NKTR has a collaboration with SNDX (where they test 214 in combo with entinostat not a development license). Again I haven't looked at SNDX to see if its related or not.

[dangerM]

... or RO6874281 (IL2-FAP fusion protein) at ESMO and that Roche might have other relevant IL2R\beta / IL2R\gamma biased AB.